Kendra W. Wong
Comptroller/Controller/Auditor en LENSAR, INC. .
Fortuna: 70 994 $ al 31/03/2024
Perfil
Kendra W.
Wong is currently working as the Principal Accounting Officer at LENSAR, Inc. She previously worked as the Assistant Controller-Subsidiary Operations at PDL BioPharma, Inc. from 2018 to 2021.
Ms. Wong holds an MBA from Arizona State University and an undergraduate degree from the University of California, Davis.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LENSAR INC
0.18% | 11/01/2023 | 20 899 ( 0.18% ) | 70 994 $ | 31/03/2024 |
Cargos activos de Kendra W. Wong
| Empresas | Cargo | Inicio |
|---|---|---|
| LENSAR, INC. | Comptroller/Controller/Auditor | 11/01/2022 |
Antiguos cargos conocidos de Kendra W. Wong.
| Empresas | Cargo | Fin |
|---|---|---|
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01/03/2021 |
Formación de Kendra W. Wong.
| Arizona State University | Masters Business Admin |
| University of California, Davis | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LENSAR, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Kendra W. Wong
